Jeffrey J. Crowley
Expertise in
91
conditions

Dr. Jeffrey J. Crowley

Dermatology
5101 Commerce Dr, Ste 101, 
Bakersfield, CA 
Accepting New Patients
Expertise in
91
conditions
5101 Commerce Dr, Ste 101, 
Bakersfield, CA 

Overview

We are dedicated to providing the best care possible for your skin. We specialize in treating and preventing skin cancer. Additionally, we maintain a busy clinical trial program focusing on psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Dr. Crowley is highly rated in 91 conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Actinic Keratosis, and Seborrheic Keratosis.

Dr. Crowley is board certified in Dermatology. He is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 11 clinical trials. Dr. Crowley is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in CA

Board Certifications

Dermatology

Hospital Affiliations

Adventist Health Bakersfield

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Jeffrey J. Crowley, M.D., Inc.
5101 Commerce Dr, Ste 101, Bakersfield, CA 93309

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Combination product
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
MAP Study (Methotrexate and Adalimumab in Psoriasis): Adalimumab vs. Combination Adalimumab and Methotrexate in Psoriasis: Efficacy and Anti-Adalimumab Antibody Formation
MAP Study (Methotrexate and Adalimumab in Psoriasis): Adalimumab vs. Combination Adalimumab and Methotrexate in Psoriasis: Efficacy and Anti-Adalimumab Antibody Formation
Enrollment Status: Completed
Publish Date: July 09, 2019
Intervention Type: Drug, Biological
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

22 Total Publications

Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis.
Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis.
Journal: Dermatology and therapy
Published: April 29, 2026
Similar Doctors
Expertise in
48
conditions
Expertise in
48
conditions
Referral may be required

Ravi Patel, M.D., Inc.

6501 Truxtun Ave, 
Bakersfield, CA 
 (1.0 miles away)
661-322-2206
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Geover Fernandez is a Dermatologist practicing medicine in Bakersfield, California. Dr. Fernandez is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Melanoma, Giant Congenital Melanocytic Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Nevus. Dr. Fernandez is board certified in Dermatology. Dr. Fernandez is currently accepting new patients.

Expertise in
29
conditions
Dr. Neal M. Ammar
Dermatology
Expertise in
29
conditions
Dr. Neal M. Ammar
Dermatology
Referral may be required

Ravi Patel, M.D., Inc.

6501 Truxtun Ave, 
Bakersfield, CA 
 (1.0 miles away)
661-322-2206
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Neal Ammar is a Dermatologist practicing medicine in Bakersfield, California. Dr. Ammar is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Melanoma, Squamous Cell Skin Carcinoma, Giant Congenital Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Ammar is board certified in Dermatology. Dr. Ammar is currently accepting new patients.

Expertise in
79
conditions
Expertise in
79
conditions
Referral may be required
Before you request

LA Laser Center PC A Professional Medical Corporation

1317 Main St, Ste B, 
Delano, CA 
 (30.0 miles away)
661-430-9070
Languages Spoken:
English, Farsi, Spanish
See accepted insurances
Accepting New Patients

Daniel Taheri is a Dermatologist practicing medicine in Delano, California. Dr. Taheri is highly rated in 79 conditions, according to our data. His clinical expertise encompasses Comedones, Melanoma, Giant Congenital Melanocytic Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Taheri is board certified in Dermatology and American Board Of Dermatology. Dr. Taheri is currently accepting new patients.

Frequently Asked Questions about Dr. Jeffrey J. Crowley

How do I make an appointment with Dr. Jeffrey J. Crowley?

You can book an appointment with Dr. Jeffrey J. Crowley by calling their office at 661-327-3756. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey J. Crowley a top-rated expert for Plaque Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey J. Crowley is classified as an Elite expert for Plaque Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey J. Crowley specialize in?

While Dr. Jeffrey J. Crowley is a Dermatology, they have specific expertise in Plaque Psoriasis, Psoriasis, and Actinic Keratosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Jeffrey J. Crowley participate in research or clinical trials?

Yes. Dr. Jeffrey J. Crowley has published 22 articles and abstracts on conditions like Plaque Psoriasis. You can view a list of Dr. Jeffrey J. Crowley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey J. Crowley accept my insurance?

Dr. Jeffrey J. Crowley accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 661-327-3756 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Crowley's expertise for a condition
ConditionClose
View All 22 Distinguished Conditions
View All 67 Advanced Conditions
View All 80 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile